593 related articles for article (PubMed ID: 32500196)
1. Outcome prediction of head and neck squamous cell carcinoma by MRI radiomic signatures.
Mes SW; van Velden FHP; Peltenburg B; Peeters CFW; Te Beest DE; van de Wiel MA; Mekke J; Mulder DC; Martens RM; Castelijns JA; Pameijer FA; de Bree R; Boellaard R; Leemans CR; Brakenhoff RH; de Graaf P
Eur Radiol; 2020 Nov; 30(11):6311-6321. PubMed ID: 32500196
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of pre-treatment magnetic resonance imaging (MRI)-based radiomic analysis in effectively cured head and neck squamous cell carcinoma (HNSCC) patients.
Alfieri S; Romanò R; Bologna M; Calareso G; Corino V; Mirabile A; Ferri A; Bellanti L; Poli T; Marcantoni A; Grosso E; Tarsitano A; Battaglia S; Blengio F; De Martino I; Valerini S; Vecchio S; Richetti A; Deantonio L; Martucci F; Grammatica A; Ravanelli M; Ibrahim T; Caruso D; Locati LD; Orlandi E; Bossi P; Mainardi L; Licitra LF
Acta Oncol; 2021 Sep; 60(9):1192-1200. PubMed ID: 34038324
[TBL] [Abstract][Full Text] [Related]
3. MRI-based radiomic signature as predictive marker for patients with head and neck squamous cell carcinoma.
Yuan Y; Ren J; Shi Y; Tao X
Eur J Radiol; 2019 Aug; 117():193-198. PubMed ID: 31307647
[TBL] [Abstract][Full Text] [Related]
4. Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy.
Keek S; Sanduleanu S; Wesseling F; de Roest R; van den Brekel M; van der Heijden M; Vens C; Giuseppina C; Licitra L; Scheckenbach K; Vergeer M; Leemans CR; Brakenhoff RH; Nauta I; Cavalieri S; Woodruff HC; Poli T; Leijenaar R; Hoebers F; Lambin P
PLoS One; 2020; 15(5):e0232639. PubMed ID: 32442178
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging based radiomics prediction of Human Papillomavirus infection status and overall survival in oropharyngeal squamous cell carcinoma.
Boot PA; Mes SW; de Bloeme CM; Martens RM; Leemans CR; Boellaard R; van de Wiel MA; de Graaf P
Oral Oncol; 2023 Feb; 137():106307. PubMed ID: 36657208
[TBL] [Abstract][Full Text] [Related]
6. Improved outcome prediction of oropharyngeal cancer by combining clinical and MRI features in machine learning models.
Bos P; van den Brekel MWM; Gouw ZAR; Al-Mamgani A; Taghavi M; Waktola S; Aerts HJWL; Castelijns JA; Beets-Tan RGH; Jasperse B
Eur J Radiol; 2021 Jun; 139():109701. PubMed ID: 33865064
[TBL] [Abstract][Full Text] [Related]
7. Machine Learning Based Radiomic HPV Phenotyping of Oropharyngeal SCC: A Feasibility Study Using MRI.
Sohn B; Choi YS; Ahn SS; Kim H; Han K; Lee SK; Kim J
Laryngoscope; 2021 Mar; 131(3):E851-E856. PubMed ID: 33070337
[TBL] [Abstract][Full Text] [Related]
8. MRI radiomics in head and neck cancer from reproducibility to combined approaches.
Corti A; Cavalieri S; Calareso G; Mattavelli D; Ravanelli M; Poli T; Licitra L; Corino VDA; Mainardi L
Sci Rep; 2024 Apr; 14(1):9451. PubMed ID: 38658630
[TBL] [Abstract][Full Text] [Related]
9. Prognostic radiomic signature for head and neck cancer: Development and validation on a multi-centric MRI dataset.
Bologna M; Corino V; Cavalieri S; Calareso G; Gazzani SE; Poli T; Ravanelli M; Mattavelli D; de Graaf P; Nauta I; Scheckenbach K; Licitra L; Mainardi L
Radiother Oncol; 2023 Jun; 183():109638. PubMed ID: 37004837
[TBL] [Abstract][Full Text] [Related]
10. Computed Tomography Radiomics Predicts HPV Status and Local Tumor Control After Definitive Radiochemotherapy in Head and Neck Squamous Cell Carcinoma.
Bogowicz M; Riesterer O; Ikenberg K; Stieb S; Moch H; Studer G; Guckenberger M; Tanadini-Lang S
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):921-928. PubMed ID: 28807534
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment ADC is not a prognostic factor for local recurrences in head and neck squamous cell carcinoma when clinical T-stage is known.
Peltenburg B; Driessen JP; Vasmel JE; Pameijer FA; Janssen LM; Terhaard CHJ; de Bree R; Philippens MEP
Eur Radiol; 2020 Feb; 30(2):1228-1231. PubMed ID: 31529258
[TBL] [Abstract][Full Text] [Related]
12. Radiomic biomarkers for head and neck squamous cell carcinoma.
Tanadini-Lang S; Balermpas P; Guckenberger M; Pavic M; Riesterer O; Vuong D; Bogowicz M
Strahlenther Onkol; 2020 Oct; 196(10):868-878. PubMed ID: 32495038
[TBL] [Abstract][Full Text] [Related]
13. Radiomics-based prediction of survival in patients with head and neck squamous cell carcinoma based on pre- and post-treatment
Liu Z; Cao Y; Diao W; Cheng Y; Jia Z; Peng X
Aging (Albany NY); 2020 Jul; 12(14):14593-14619. PubMed ID: 32674074
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of a Model Using Radiomics Features from an Apparent Diffusion Coefficient Map to Diagnose Local Tumor Recurrence in Patients Treated for Head and Neck Squamous Cell Carcinoma.
Kim M; Lee JH; Joo L; Jeong B; Kim S; Ham S; Yun J; Kim N; Chung SR; Choi YJ; Baek JH; Lee JY; Kim JH
Korean J Radiol; 2022 Nov; 23(11):1078-1088. PubMed ID: 36126954
[TBL] [Abstract][Full Text] [Related]
15. Application of contrast-enhanced CT radiomics in prediction of early recurrence of locally advanced oesophageal squamous cell carcinoma after trimodal therapy.
Tang S; Ou J; Liu J; Wu YP; Wu CQ; Chen TW; Zhang XM; Li R; Tang MJ; Yang LQ; Tan BG; Lu FL; Hu J
Cancer Imaging; 2021 May; 21(1):38. PubMed ID: 34039403
[TBL] [Abstract][Full Text] [Related]
16. Association of quantitative MRI-based radiomic features with prognostic factors and recurrence rate in oropharyngeal squamous cell carcinoma.
Giannitto C; Marvaso G; Botta F; Raimondi S; Alterio D; Ciardo D; Volpe S; De Piano F; Ancona E; Tagliabue M; Origgi D; Chiocca S; Maffini FA; Ansarin M; Bagnardi V; Cattani F; Nolè F; Preda L; Orecchia R; Cassano E; Cremonesi M; Starzyńska A; Bellomi M; Jereczek-Fossa BA
Neoplasma; 2020 Nov; 67(6):1437-1446. PubMed ID: 32787435
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging based radiomics signature for the preoperative discrimination of stage I-II and III-IV head and neck squamous cell carcinoma.
Ren J; Tian J; Yuan Y; Dong D; Li X; Shi Y; Tao X
Eur J Radiol; 2018 Sep; 106():1-6. PubMed ID: 30150029
[TBL] [Abstract][Full Text] [Related]
18. MRI Radiomic Features: Association with Disease-Free Survival in Patients with Triple-Negative Breast Cancer.
Kim S; Kim MJ; Kim EK; Yoon JH; Park VY
Sci Rep; 2020 Feb; 10(1):3750. PubMed ID: 32111957
[TBL] [Abstract][Full Text] [Related]
19. MRI-based radiomic prognostic signature for locally advanced oral cavity squamous cell carcinoma: development, testing and comparison with genomic prognostic signatures.
Corti A; De Cecco L; Cavalieri S; Lenoci D; Pistore F; Calareso G; Mattavelli D; de Graaf P; Leemans CR; Brakenhoff RH; Ravanelli M; Poli T; Licitra L; Corino V; Mainardi L
Biomark Res; 2023 Jul; 11(1):69. PubMed ID: 37455307
[TBL] [Abstract][Full Text] [Related]
20. CT imaging during treatment improves radiomic models for patients with locally advanced head and neck cancer.
Leger S; Zwanenburg A; Pilz K; Zschaeck S; Zöphel K; Kotzerke J; Schreiber A; Zips D; Krause M; Baumann M; Troost EGC; Richter C; Löck S
Radiother Oncol; 2019 Jan; 130():10-17. PubMed ID: 30087056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
